The economic burden of rare diseases seems to be 10 times higher than the burden for mass diseases. Rare diseases impose a substantial economic burden according to a new report from Chiesi Global Rare Diseases with support from IQVIA. In fact, the economic...
We are now ISO 13485 certified. We are proud to announce that we are now certified with ISO 13485, within the scope “Design and Development and Service Provision of In Vitro Diagnostic Medical device software”. The ISO 13485:2016 specifies the...
How precision genomics and digital technologies could disrupt healthcare What is precision genomics, and how will this space work with digital technologies? Precision genomics medicine is a customized medical approach that focuses on identifying and optimizing...
gMendel announces cooperation with Polish biotech company genXone gMendel has signed a letter of intent with genXone, an innovative company operating in the biotechnology industry in Poland. In this letter the companies declare their willingness to cooperate in...
A new way to find genetic variations removes bias from human genotyping Since the first international effort to sequence the 3 billion DNA letters in the human genome (The Human Genome Project), the study of human genomes has relied almost exclusively on a...
Access inequality for European children to newborn screening Children across Europe are facing early death or lifelong disability because of a lack of access to disease diagnosis through existing newborn screening (NBS) programs. Now is the time to ensure all...
Recent Comments